Article 31 7.

all its implications, particularly to take account of the diversity of European ecosystems and the need to complement the regulatory framework in this field;

the feasibility of various options to improve further the consistency and efficiency of this framework, including a centralised Community authorisation procedure and the arrangements for the final decision making by the Commission;

whether sufficient experience has accumulated on the implementation of part B differentiated procedures to justify a provision on implicit consent in these procedures and on part C to justify the application of differentiated procedures; and

the socioeconomic implications of deliberate releases and placing on the market of GMOs.